aluates Reports

$ 0.0

Automative

Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-26P6039

Global Clinical Oncology Next Generation Sequencing NGS Market Insights Forecast to 2028

BUY CHAPTERS

Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2024

Code: QYRE-Auto-26P6039

Report

January 2024

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Clinical Oncology Next Generation Sequencing (NGS) Market Size

The global Clinical Oncology Next Generation Sequencing (NGS) market was valued at US$ 704.7 million in 2023 and is anticipated to reach US$ 1429.7 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.

Clinical Oncology Next Generation Sequencing (NGS) Market

NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.

The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.

This report aims to provide a comprehensive presentation of the global market for Clinical Oncology Next Generation Sequencing (NGS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Oncology Next Generation Sequencing (NGS).

Report Scope

The Clinical Oncology Next Generation Sequencing (NGS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Oncology Next Generation Sequencing (NGS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Clinical Oncology Next Generation Sequencing (NGS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Clinical Oncology Next Generation Sequencing (NGS) Market Report

Report Metric	Details
Report Name	Clinical Oncology Next Generation Sequencing (NGS) Market
Accounted market size in 2023	US$ 704.7 million
Forecasted market size in 2030	US$ 1429.7 million
CAGR	10.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	NGS Pre-Sequencing Sequencing NGS Data Analysis Primary, Secondary & Tertiary Data Analysis
Segment by Application	Academic & Clinical Research Hospitals & Clinics Pharma & Biotech Entities
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen, Life Technologies, DNASTAR, Exosome Diagnostics, Biomatters, CLC Bio, BGI, Qiagen, Perkin Elmer, Pacific Bioscience, Partek, GnuBIO, Foundation Medicine, Paradigm, Caris Life Sciences, Myriad Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Oncology Next Generation Sequencing (NGS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Clinical Oncology Next Generation Sequencing (NGS) Market growing?

Ans: The Clinical Oncology Next Generation Sequencing (NGS) Market witnessing a CAGR of 10.6% during the forecast period 2024-2030.

What is the Clinical Oncology Next Generation Sequencing (NGS) Market size in 2030?

Ans: The Clinical Oncology Next Generation Sequencing (NGS) Market size in 2030 will be US$ 1429.7 million.

Who are the main players in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

Ans: The main players in the Clinical Oncology Next Generation Sequencing (NGS) Market are Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen, Life Technologies, DNASTAR, Exosome Diagnostics, Biomatters, CLC Bio, BGI, Qiagen, Perkin Elmer, Pacific Bioscience, Partek, GnuBIO, Foundation Medicine, Paradigm, Caris Life Sciences, Myriad Genetics

What are the Application segmentation covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

Ans: The Applications covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report are Academic & Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities

What are the Type segmentation covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

Ans: The Types covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report are NGS Pre-Sequencing, Sequencing, NGS Data Analysis, Primary, Secondary & Tertiary Data Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NGS Pre-Sequencing

1.2.3 Sequencing

1.2.4 NGS Data Analysis

1.2.5 Primary, Secondary & Tertiary Data Analysis

1.3 Market by Application

1.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Academic & Clinical Research

1.3.3 Hospitals & Clinics

1.3.4 Pharma & Biotech Entities

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Perspective (2019-2030)

2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Region

2.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Historic Market Size by Region (2019-2024)

2.2.3 Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Region (2025-2030)

2.3 Clinical Oncology Next Generation Sequencing (NGS) Market Dynamics

2.3.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Trends

2.3.2 Clinical Oncology Next Generation Sequencing (NGS) Market Drivers

2.3.3 Clinical Oncology Next Generation Sequencing (NGS) Market Challenges

2.3.4 Clinical Oncology Next Generation Sequencing (NGS) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Clinical Oncology Next Generation Sequencing (NGS) Players by Revenue

3.1.1 Global Top Clinical Oncology Next Generation Sequencing (NGS) Players by Revenue (2019-2024)

3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players (2019-2024)

3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Clinical Oncology Next Generation Sequencing (NGS) Revenue

3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio

3.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2023

3.5 Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Area Served

3.6 Key Players Clinical Oncology Next Generation Sequencing (NGS) Product Solution and Service

3.7 Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Oncology Next Generation Sequencing (NGS) Breakdown Data by Type

4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Historic Market Size by Type (2019-2024)

4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Type (2025-2030)

5 Clinical Oncology Next Generation Sequencing (NGS) Breakdown Data by Application

5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Historic Market Size by Application (2019-2024)

5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2019-2030)

6.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)

6.4 North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size (2019-2030)

7.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)

7.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size (2019-2030)

8.2 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024)

8.4 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2019-2030)

9.2 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)

9.4 Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size (2019-2030)

10.2 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)

10.4 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Detail

11.1.2 Illumina Business Overview

11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.1.5 Illumina Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Detail

11.3.2 Agilent Technologies Business Overview

11.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.3.5 Agilent Technologies Recent Development

11.4 Knome

11.4.1 Knome Company Detail

11.4.2 Knome Business Overview

11.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.4.5 Knome Recent Development

11.5 Genomatix Software

11.5.1 Genomatix Software Company Detail

11.5.2 Genomatix Software Business Overview

11.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.5.5 Genomatix Software Recent Development

11.6 GATC Biotech

11.6.1 GATC Biotech Company Detail

11.6.2 GATC Biotech Business Overview

11.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.6.5 GATC Biotech Recent Development

11.7 Oxford Nanopore Technologies

11.7.1 Oxford Nanopore Technologies Company Detail

11.7.2 Oxford Nanopore Technologies Business Overview

11.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.7.5 Oxford Nanopore Technologies Recent Development

11.8 Macrogen

11.8.1 Macrogen Company Detail

11.8.2 Macrogen Business Overview

11.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.8.5 Macrogen Recent Development

11.9 Life Technologies

11.9.1 Life Technologies Company Detail

11.9.2 Life Technologies Business Overview

11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.9.5 Life Technologies Recent Development

11.10 DNASTAR

11.10.1 DNASTAR Company Detail

11.10.2 DNASTAR Business Overview

11.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.10.5 DNASTAR Recent Development

11.11 Exosome Diagnostics

11.11.1 Exosome Diagnostics Company Detail

11.11.2 Exosome Diagnostics Business Overview

11.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.11.4 Exosome Diagnostics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.11.5 Exosome Diagnostics Recent Development

11.12 Biomatters

11.12.1 Biomatters Company Detail

11.12.2 Biomatters Business Overview

11.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.12.4 Biomatters Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.12.5 Biomatters Recent Development

11.13 CLC Bio

11.13.1 CLC Bio Company Detail

11.13.2 CLC Bio Business Overview

11.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.13.4 CLC Bio Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.13.5 CLC Bio Recent Development

11.14 BGI

11.14.1 BGI Company Detail

11.14.2 BGI Business Overview

11.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.14.4 BGI Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.14.5 BGI Recent Development

11.15 Qiagen

11.15.1 Qiagen Company Detail

11.15.2 Qiagen Business Overview

11.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.15.4 Qiagen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.15.5 Qiagen Recent Development

11.16 Perkin Elmer

11.16.1 Perkin Elmer Company Detail

11.16.2 Perkin Elmer Business Overview

11.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.16.4 Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.16.5 Perkin Elmer Recent Development

11.17 Pacific Bioscience

11.17.1 Pacific Bioscience Company Detail

11.17.2 Pacific Bioscience Business Overview

11.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.17.4 Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.17.5 Pacific Bioscience Recent Development

11.18 Partek

11.18.1 Partek Company Detail

11.18.2 Partek Business Overview

11.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.18.4 Partek Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.18.5 Partek Recent Development

11.19 GnuBIO

11.19.1 GnuBIO Company Detail

11.19.2 GnuBIO Business Overview

11.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.19.4 GnuBIO Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.19.5 GnuBIO Recent Development

11.20 Foundation Medicine

11.20.1 Foundation Medicine Company Detail

11.20.2 Foundation Medicine Business Overview

11.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.20.4 Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.20.5 Foundation Medicine Recent Development

11.21 Paradigm

11.21.1 Paradigm Company Detail

11.21.2 Paradigm Business Overview

11.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.21.4 Paradigm Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.21.5 Paradigm Recent Development

11.22 Caris Life Sciences

11.22.1 Caris Life Sciences Company Detail

11.22.2 Caris Life Sciences Business Overview

11.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.22.4 Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.22.5 Caris Life Sciences Recent Development

11.23 Myriad Genetics

11.23.1 Myriad Genetics Company Detail

11.23.2 Myriad Genetics Business Overview

11.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Introduction

11.23.4 Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

11.23.5 Myriad Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NGS Pre-Sequencing

Table 3. Key Players of Sequencing

Table 4. Key Players of NGS Data Analysis

Table 5. Key Players of Primary, Secondary & Tertiary Data Analysis

Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Region (2019-2024)

Table 10. Global Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Region (2025-2030)

Table 12. Clinical Oncology Next Generation Sequencing (NGS) Market Trends

Table 13. Clinical Oncology Next Generation Sequencing (NGS) Market Drivers

Table 14. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges

Table 15. Clinical Oncology Next Generation Sequencing (NGS) Market Restraints

Table 16. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Players (2019-2024)

Table 18. Global Top Clinical Oncology Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2023)

Table 19. Ranking of Global Top Clinical Oncology Next Generation Sequencing (NGS) Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Clinical Oncology Next Generation Sequencing (NGS) Product Solution and Service

Table 23. Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Type (2019-2024)

Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Type (2025-2030)

Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application (2019-2024)

Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application (2025-2030)

Table 33. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2025-2030) & (US$ Million)

Table 48. Illumina Company Detail

Table 49. Illumina Business Overview

Table 50. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product

Table 51. Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 52. Illumina Recent Development

Table 53. Roche Company Detail

Table 54. Roche Business Overview

Table 55. Roche Clinical Oncology Next Generation Sequencing (NGS) Product

Table 56. Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Agilent Technologies Company Detail

Table 59. Agilent Technologies Business Overview

Table 60. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product

Table 61. Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 62. Agilent Technologies Recent Development

Table 63. Knome Company Detail

Table 64. Knome Business Overview

Table 65. Knome Clinical Oncology Next Generation Sequencing (NGS) Product

Table 66. Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 67. Knome Recent Development

Table 68. Genomatix Software Company Detail

Table 69. Genomatix Software Business Overview

Table 70. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product

Table 71. Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 72. Genomatix Software Recent Development

Table 73. GATC Biotech Company Detail

Table 74. GATC Biotech Business Overview

Table 75. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product

Table 76. GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 77. GATC Biotech Recent Development

Table 78. Oxford Nanopore Technologies Company Detail

Table 79. Oxford Nanopore Technologies Business Overview

Table 80. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product

Table 81. Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 82. Oxford Nanopore Technologies Recent Development

Table 83. Macrogen Company Detail

Table 84. Macrogen Business Overview

Table 85. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product

Table 86. Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 87. Macrogen Recent Development

Table 88. Life Technologies Company Detail

Table 89. Life Technologies Business Overview

Table 90. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product

Table 91. Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 92. Life Technologies Recent Development

Table 93. DNASTAR Company Detail

Table 94. DNASTAR Business Overview

Table 95. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product

Table 96. DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 97. DNASTAR Recent Development

Table 98. Exosome Diagnostics Company Detail

Table 99. Exosome Diagnostics Business Overview

Table 100. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product

Table 101. Exosome Diagnostics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 102. Exosome Diagnostics Recent Development

Table 103. Biomatters Company Detail

Table 104. Biomatters Business Overview

Table 105. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product

Table 106. Biomatters Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 107. Biomatters Recent Development

Table 108. CLC Bio Company Detail

Table 109. CLC Bio Business Overview

Table 110. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product

Table 111. CLC Bio Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 112. CLC Bio Recent Development

Table 113. BGI Company Detail

Table 114. BGI Business Overview

Table 115. BGI Clinical Oncology Next Generation Sequencing (NGS) Product

Table 116. BGI Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 117. BGI Recent Development

Table 118. Qiagen Company Detail

Table 119. Qiagen Business Overview

Table 120. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product

Table 121. Qiagen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 122. Qiagen Recent Development

Table 123. Perkin Elmer Company Detail

Table 124. Perkin Elmer Business Overview

Table 125. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product

Table 126. Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 127. Perkin Elmer Recent Development

Table 128. Pacific Bioscience Company Detail

Table 129. Pacific Bioscience Business Overview

Table 130. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product

Table 131. Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 132. Pacific Bioscience Recent Development

Table 133. Partek Company Detail

Table 134. Partek Business Overview

Table 135. Partek Clinical Oncology Next Generation Sequencing (NGS) Product

Table 136. Partek Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 137. Partek Recent Development

Table 138. GnuBIO Company Detail

Table 139. GnuBIO Business Overview

Table 140. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product

Table 141. GnuBIO Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 142. GnuBIO Recent Development

Table 143. Foundation Medicine Company Detail

Table 144. Foundation Medicine Business Overview

Table 145. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product

Table 146. Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 147. Foundation Medicine Recent Development

Table 148. Paradigm Company Detail

Table 149. Paradigm Business Overview

Table 150. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product

Table 151. Paradigm Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 152. Paradigm Recent Development

Table 153. Caris Life Sciences Company Detail

Table 154. Caris Life Sciences Business Overview

Table 155. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product

Table 156. Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 157. Caris Life Sciences Recent Development

Table 158. Myriad Genetics Company Detail

Table 159. Myriad Genetics Business Overview

Table 160. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product

Table 161. Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024) & (US$ Million)

Table 162. Myriad Genetics Recent Development

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type: 2023 VS 2030

Figure 3. NGS Pre-Sequencing Features

Figure 4. Sequencing Features

Figure 5. NGS Data Analysis Features

Figure 6. Primary, Secondary & Tertiary Data Analysis Features

Figure 7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application: 2023 VS 2030

Figure 9. Academic & Clinical Research Case Studies

Figure 10. Hospitals & Clinics Case Studies

Figure 11. Pharma & Biotech Entities Case Studies

Figure 12. Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered

Figure 13. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Region: 2023 VS 2030

Figure 16. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Players in 2023

Figure 17. Global Top Clinical Oncology Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2023

Figure 19. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Country (2019-2030)

Figure 21. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Country (2019-2030)

Figure 25. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Share by Region (2019-2030)

Figure 33. China Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Country (2019-2030)

Figure 41. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Share by Country (2019-2030)

Figure 45. Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Illumina Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 48. Roche Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 49. Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 50. Knome Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 51. Genomatix Software Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 52. GATC Biotech Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 53. Oxford Nanopore Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 54. Macrogen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 55. Life Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 56. DNASTAR Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 57. Exosome Diagnostics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 58. Biomatters Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 59. CLC Bio Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 60. BGI Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 61. Qiagen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 62. Perkin Elmer Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 63. Pacific Bioscience Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 64. Partek Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 65. GnuBIO Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 66. Foundation Medicine Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 67. Paradigm Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 68. Caris Life Sciences Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 69. Myriad Genetics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-26P6039

Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2024

FEATURED COMPANIES

Clinical Oncology Next Generation Sequencing (NGS) Market Size

Clinical Oncology Next Generation Sequencing (NGS) Market

Report Scope

Scope of Clinical Oncology Next Generation Sequencing (NGS) Market Report

Chapter Outline

FAQ for this report

How fast is Clinical Oncology Next Generation Sequencing (NGS) Market growing?

What is the Clinical Oncology Next Generation Sequencing (NGS) Market size in 2030?

Who are the main players in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

What are the Application segmentation covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

What are the Type segmentation covered in the Clinical Oncology Next Generation Sequencing (NGS) Market report?

FEATURED COMPANIES